Ask AI
ProCE Banner Activity

Novel Approaches in Multiple Myeloma: Expert Perspectives on Emerging Data and Ongoing Trials

Slideset

Download this slideset from a recent symposium with expert perspectives on novel protein degraders for patients with multiple myeloma.

Released: June 10, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

This activity is supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Target Audience

This activity is intended for hematologists, oncologists, and other healthcare professionals who care for patients with multiple myeloma.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Analyze the impact of binding affinity and potency on the antimyeloma activity of individual novel agents and approaches

  • Evaluate the potential clinical implications of emerging data for novel therapies on treatment of multiple myeloma across the disease continuum

  • Identify patients with multiple myeloma who may be eligible for and likely to benefit from enrollment on clinical trials investigating novel therapies